IL2 and colon adenocarcinoma: Herein, the maintenance of the cytolytic activity of ex vivo TKD/IL-2-activated PBMNC against a classical NK target and the autologous, Hsp70 membrane-positive tumor of a patient with an anastomotic relapse of a colon adenocarcinoma was tested.